AKT1 and schizophrenia: Here, we conducted the first studies, to our knowledge, in an animal model where a genetic deletion that disrupts Akt phosphorylation enhances expression of NET and leads to a cortical hypodopaminergic phenotype with schizophrenia-linked behavioral consequences.